Cell News and Research

RSS
PTSD patients with Met-66 allele of BDNF show poorer response to exposure therapy

PTSD patients with Met-66 allele of BDNF show poorer response to exposure therapy

New collaboration to advance cancer immunotherapy research

New collaboration to advance cancer immunotherapy research

Esophageal cancer: A serious threat to African-American men

Esophageal cancer: A serious threat to African-American men

Slowdowns in transport of important molecules may contribute to development of ALS

Slowdowns in transport of important molecules may contribute to development of ALS

Effective method to restore sight to patients with blinding diseases

Effective method to restore sight to patients with blinding diseases

Teenage victims of cyberbullying at higher risk for psychological, behavior health problems

Teenage victims of cyberbullying at higher risk for psychological, behavior health problems

SAP and TUM decode human proteome and provide data for biomedical research

SAP and TUM decode human proteome and provide data for biomedical research

Bacterium that causes gum disease delivers one-two punch by triggering protective proteins in oral cavity

Bacterium that causes gum disease delivers one-two punch by triggering protective proteins in oral cavity

Hypometabolism in brain regions of cognitively normal patients associated with Alzheimer's disease

Hypometabolism in brain regions of cognitively normal patients associated with Alzheimer's disease

Study reveals radioimmunotherapy can improve survival rates of patients with aggressive lymphoma

Study reveals radioimmunotherapy can improve survival rates of patients with aggressive lymphoma

Scheduled exercise, regular meals and periodic warming relieve symptoms of osteoarthritis

Scheduled exercise, regular meals and periodic warming relieve symptoms of osteoarthritis

Tumor suppressor p53 inactivation and restoration: an interview with Dr. Xin Lu, Ludwig Institute for Cancer Research

Tumor suppressor p53 inactivation and restoration: an interview with Dr. Xin Lu, Ludwig Institute for Cancer Research

Sequenom CMM completes build-out, validation of additional lab facility in Raleigh-Durham, NC

Sequenom CMM completes build-out, validation of additional lab facility in Raleigh-Durham, NC

Researchers to launch Phase II clinical trial to investigate potential new therapy for sickle cell anemia

Researchers to launch Phase II clinical trial to investigate potential new therapy for sickle cell anemia

Hebrew University student develops drug formulations to treat illnesses through skin applications

Hebrew University student develops drug formulations to treat illnesses through skin applications

Drug development could be improved with stem cell technology, say researchers

Drug development could be improved with stem cell technology, say researchers

TSRI scientists identify key triggers of cancer-blocking mechanism in cells

TSRI scientists identify key triggers of cancer-blocking mechanism in cells

Mayo Clinic announces first US stem cell clinical trial for children with hypoplastic left heart syndrome

Mayo Clinic announces first US stem cell clinical trial for children with hypoplastic left heart syndrome

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Hybrid molecular imaging technique helps doctors identify diabetic foot infection

Hybrid molecular imaging technique helps doctors identify diabetic foot infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.